Pharma Firms Reject Anthropic's Data Requests, Making Data the Moat for AI Drug Discovery
Hesamation · x · 2026-07-07
A blogger pointed out that Anthropic was unanimously rejected by major pharmaceutical companies when requesting data, arguing this is a primary reason why AI has triumphed in software but has yet to make major scientific discoveries.
The analysis suggests pharma companies recognize data as their moat and refuse to hand it over. The blogger further predicts more companies will realize this and turn to open-source solutions to 'own their weights'.
Related event: Anthropic Denied Data Access by Big Pharma(2 posts)→
More from Companies & People
- Anthropic Insiders: Not Everyone at the Lab Believes in High p(doom) — anpaure · 2026-09-11
- Lumara AI Film Festival Comes to NYC Oct 26, Top AI Filmmakers to Compete — 0xAllen_ · 2026-09-11
- X drama: Anthropic researchers accused of spying on academic customers and racing them to results — basedjensen · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- a16z podcast: why 2-3 person startups are absent from policy debates — a16z Podcast · 2026-09-11
- PyTorch Day Korea 2026 launches first offline conf, CFP closes Sept 13 — PyTorch · 2026-09-11